SHAWN CASSADY: Open Payments
NPI 1902912918 · ABERDEEN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 11 payments from 8 companies in 2025. Trend: 2023 $175 · 2024 $281 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $71 |
| E.R. Squibb & Sons, L.L.C. | 2 | $61 |
| Janssen Pharmaceuticals, Inc | 1 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $25 |
| Alkermes, Inc. | 1 | $18 |
| TMS NeuroHealth Centers Inc. | 1 | $9 |
Products named: VRAYLAR, COBENFY, SPRAVATO, INGREZZA, UZEDY, REXULTI, ARISTADA, TMS NeuroHealth Centers Inc..
Industry payments across MD — which companies pay providers there.
